Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria

Carmichael Katie; Nolan Sarah J.; Weston Jennifer; Smith Catrin Tudur; Marson Anthony G.

首页> 外文期刊>Epilepsy research >Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria

【24h】

Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria

机译：使用CONSORT标准评估托吡酯治疗癫痫的非随机研究和随机对照研究中危害报告的质量

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Treatment decisions should be informed by high quality evidence of both the potential benefit and harms of treatment alternatives. Randomised controlled trials (RCTs) provide the best evidence regarding benefits; however information relating to serious, rare and long-term harms is usually available only from non-randomised studies (NRSs). The aim of this study was to use a checklist based on the CONSORT (Consolidating Standards for Reporting Trials) extension for harms recommendations to assess the quality of reporting of harms data in both NRSs and RCTs of antiepileptic drugs, using studies of topiramate as an example.

机译：目的：治疗决策应以高质量的证据告知治疗替代方案的潜在利弊。随机对照试验（RCT）提供了有关益处的最佳证据;但是，有关严重，罕见和长期危害的信息通常只能从非随机研究（NRS）中获得。这项研究的目的是使用基于CONSORT（报告试验的合并标准）扩展名的清单进行危害建议，以托吡酯研究为例，评估抗癫痫药的NRS和RCT中危害数据的报告质量。。

著录项

来源
《Epilepsy research》 |2015年第null期|共8页
作者
Carmichael Katie; Nolan Sarah J.; Weston Jennifer; Smith Catrin Tudur; Marson Anthony G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词
CONSORT; Randomised controlled trial; Non-randomised; Harms; Adverse events; Topiramate;

机译：CONSORT;随机对照试验;非随机;危害;不良事件;托吡酯;

相似文献

外文文献
中文文献
专利

1. Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria [J] . Carmichael Katie, Nolan Sarah J., Weston Jennifer, Epilepsy research . 2015,第Null期

机译：使用CONSORT标准评估托吡酯治疗癫痫的非随机研究和随机对照研究中危害报告的质量
2. Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms. [J] . Shukralla AA, Tudur Smith C, Powell GA, Epilepsy research . 2011,第1a2期

机译：利用联盟危害报告抗癫痫药物随机对照试验的不良事件。
3. Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms. [J] . Shukralla AA, Tudur Smith C, Powell GA, Epilepsy research . 2011,第1a2期

机译：利用联盟危害报告抗癫痫药物随机对照试验的不良事件。
4. Randomized controlled trials of abdominal acupuncture (1992–2012): An assessment of reporting quality with a CONSORT- and STRICTA-based instrument [C] . Jiang Shuo, Zhong Ping, Huang Qiuping, 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops. . 2012

机译：腹部针灸的随机对照试验（1992-2012年）：使用基于CONSORT和STRICTA的仪器对报告质量进行评估
5. Study quality in SLA: A cumulative and developmental assessment of designs, analyses, reporting practices, and outcomes in quantitative L2 research. [D] . Plonsky, Luke. 2011

机译：SLA中的研究质量：定量L2研究中对设计，分析，报告实践和结果的累积和发展评估。
6. The SANAD study of effectiveness of carbamazepine gabapentin lamotrigine oxcarbazepine or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial [O] . Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, -1

机译：SANAD研究卡马西平加巴喷丁拉莫三嗪奥卡西平或托吡酯治疗部分性癫痫的有效性：一项无盲随机对照试验
7. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial [O] . Marson, Anthony G., Al-Kharusi, Asya M., Alwaidh, Muna, 2007

机译：SANAD研究卡马西平，加巴喷丁，拉莫三嗪，奥卡西平或托吡酯治疗部分性癫痫的有效性：一项无盲随机对照试验

Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria

摘要

著录项

相似文献

相关主题

期刊订阅